CXCR3 and COVID-19: During acute COVID-19, B cells showed a reduced expression of CXCR3, CXCR5 and integrin β7 according to disease severity, with CXCR3 and CXCR5 level normalization in convalescent subjects (Shuwa et al., 2021).